.png "Carol Langford, MD, MHS photo")
Cleveland Clinic
Moreland Hills, Ohio, United States
Carol A. Langford, MD, MHS, received her medical degree at the University of California Los Angeles in 1987 and trained in internal medicine at the University of Michigan from 1987 to 1990. She was a fellow in rheumatology at Duke University from 1990 to 1994 where she also received a Master’s degree in health sciences in 1995. From 1994 to 2004, Dr. Langford was a senior investigator at the National Institutes of Health where her research focused on vasculitic diseases. In 2004, Dr. Langford joined the Cleveland Clinic to become Director of the Center for Vasculitis Care and Research within the Department of Rheumatic and Immunologic Diseases. She is Professor of Medicine of the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and became Vice-Chair of Rheumatology for Research in 2007. In 2011, she was named the Harold C Schott endowed Chair in Rheumatic and Immunologic Diseases. In 2023, Dr. Langford joined the Editor team for Harrison’s Principles of Internal Medicine 22nd Edition.
Saturday, November 16, 2024
1:00 PM – 1:15 PM Eastern Time
Disclosure information not submitted.
Treatment Guidelines and New Therapeutics for GPA and AAV
Sunday, November 17, 2024
9:00 AM – 9:30 AM Eastern Time
Disclosure(s): AbbVie: Non-paid consultant (Ongoing); AstraZeneca: Grant/Research Support (Ongoing), Non-paid consultant (Ongoing); Bristol-Myers Squibb(BMS): Grant/Research Support (Ongoing), Non-paid consultant (Ongoing); GlaxoSmithKlein(GSK): Grant/Research Support (Ongoing)
17S48: Development of Treatment Response Criteria for Giant Cell Arteritis
Sunday, November 17, 2024
3:30 PM – 5:00 PM Eastern Time
Disclosure(s): AbbVie: Non-paid consultant (Ongoing); AstraZeneca: Grant/Research Support (Ongoing), Non-paid consultant (Ongoing); Bristol-Myers Squibb(BMS): Grant/Research Support (Ongoing), Non-paid consultant (Ongoing); GlaxoSmithKlein(GSK): Grant/Research Support (Ongoing)
